赛马鲁肽
医学
超重
肥胖
减肥
内科学
干预(咨询)
糖尿病
2型糖尿病
内分泌学
利拉鲁肽
精神科
作者
John Wilding,Rachel L. Batterham,Salvatore Calanna,Melanie J. Davies,Luc F. Van Gaal,Ildiko Lingvay,Barbara McGowan,Julio Rosenstock,Marie Thi Dao Tran,Thomas A. Wadden,Sean Wharton,Koutaro Yokote,Niels Zeuthen,Robert F. Kushner
标识
DOI:10.1056/nejmoa2032183
摘要
In participants with overweight or obesity, 2.4 mg of semaglutide once weekly plus lifestyle intervention was associated with sustained, clinically relevant reduction in body weight. (Funded by Novo Nordisk; STEP 1 ClinicalTrials.gov number, NCT03548935).
科研通智能强力驱动
Strongly Powered by AbleSci AI